The epidemic did not close the door to the market, and another unicorn started its listing process.
The official website of the Beijing Securities Regulatory Commission announced on the evening of February 28. On December 5, 2019, the China Cambrian and CITIC Securities signed the A-share listing guidance agreement, which will start the process of the issuance and listing of the science and technology board.
It is generally believed that if the Cambrian successfully landed on the science and technology board, it would become the “first chip of AI chip” without any doubt.
The Cambrian, which was founded in 2016, has already heard the news about its listing last year.
In March 2019, Liu Qingfeng, Chairman of HKUST Xunfei, said at the “HKUST Xunfei AI New Product Media Tasting Conference” recently that the Cambrian and other companies invested by the company are actively exploring the possibility of landing on the Science and Technology Innovation Board. .
However, during the Cambrian interview with the Economic Observer, said a>, “There are no plans to become a public company, let alone an IPO, and it is a distance of 108,000 miles from the science and technology board.”
But subsequent Cambrian changes to business information are clearly preparing for an IPO.
On November 29, 2019, the name of the Cambrian company was changed from “Beijing Zhongke Cambrian Technology Co., Ltd.” to “Zhongke Cambrian Technology Co., Ltd.”, and the company type was changed from “Limited liability company (natural person Investment or holding) “to” other joint stock company (unlisted) “in order to comply with the relevant provisions of the Securities Law on listing.
Tianyancha data shows that there have been five rounds of financing since the establishment of the Cambrian, the most recent of which was in September 2019. The investor was Dongfang Sanrong CMB International Capital and Profit Capital. The financing amount has not been disclosed for the time being.